Comparison of the Efficacy of Daily and Weekly Oral Alendronate Treatment in Patients with Secondary Osteoporosis

Creative Commons License

Acar S., Paketci A., DEMİR K., BÖBER E., ABACI A.

IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI, cilt.9, sa.3, ss.191-198, 2019 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5222/buchd.2019.25349
  • Dergi Adı: IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.191-198
  • Anahtar Kelimeler: Alendronate, bisphosphonate, bone mineral density, chronic diseases, secondary osteoporosis, BONE-MINERAL DENSITY, CEREBRAL-PALSY, CHILDREN, ADOLESCENTS, MULTICENTER, MANAGEMENT, FRACTURES, SAFETY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: The use of alendronate, one of the bisphosphonates that can be used orally in the treatment of osteoporosis, has become widespread in recent years. In this study, we aimed to compare the efficacy of these two different treatment regimens such as weekly and daily oral alendronate in patients with secondary osteoporosis.